NAS:VRAY (USA)
Business Description
ViewRay Inc
NAICS : 334510
SIC : 3842
2 Thermo Fisher Way, Oakwood Village, OH, USA, 44146
Description
ViewRay Inc is a radiation therapy and imaging technology company. It designs, manufactures and markets radiation therapy systems that provide real-time imaging during radiation treatment. Its product portfolio encompasses The MRIdian linac system, The MRIdian system, the Monte Carlo treatment planning system, etc. The company holds the license for its combination of MRI and radiation therapy technologies.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.32 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.54 | |||||
| Debt-to-EBITDA | -0.7 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -1.8 | |||||
| Beneish M-Score | -3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -24.7 | |||||
| 3-Year EBITDA Growth Rate | 8.9 | |||||
| 3-Year EPS without NRI Growth Rate | 11.9 | |||||
| 3-Year FCF Growth Rate | 37.1 | |||||
| 3-Year Book Growth Rate | -18.3 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 9.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.29 | |||||
| 9-Day RSI | 65.84 | |||||
| 14-Day RSI | 62.71 | |||||
| 6-1 Month Momentum % | -32.04 | |||||
| 12-1 Month Momentum % | -51.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.04 | |||||
| Quick Ratio | 2.66 | |||||
| Cash Ratio | 2.05 | |||||
| Days Inventory | 154.82 | |||||
| Days Sales Outstanding | 108.76 | |||||
| Days Payable | 62.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -23 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 3.56 | |||||
| Operating Margin % | -133.94 | |||||
| Net Margin % | -131.2 | |||||
| ROE % | -75.64 | |||||
| ROA % | -36.95 | |||||
| ROIC % | -122.91 | |||||
| ROC (Joel Greenblatt) % | -280.46 | |||||
| ROCE % | -47.12 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 7.29 | |||||
| PB Ratio | 4.9 | |||||
| Price-to-Tangible-Book | 4.71 | |||||
| EV-to-EBIT | -5.12 | |||||
| EV-to-EBITDA | -5.39 | |||||
| EV-to-Revenue | 6.49 | |||||
| EV-to-Forward-Revenue | 5.14 | |||||
| EV-to-FCF | -6.64 | |||||
| Price-to-Net-Current-Asset-Value | 7.29 | |||||
| Price-to-Net-Cash | 109.33 | |||||
| Earnings Yield (Greenblatt) % | -19.57 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:VRAY
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 80.589 | ||
| EPS (TTM) ($) | -0.604 | ||
| Beta | 1.12 | ||
| Volatility % | 57.02 | ||
| 14-Day RSI | 62.71 | ||
| 14-Day ATR ($) | 0.206497 | ||
| 20-Day SMA ($) | 3.0365 | ||
| 12-1 Month Momentum % | -51.79 | ||
| 52-Week Range ($) | 2.39 - 8.25 | ||
| Shares Outstanding (Mil) | 181.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ViewRay Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||